查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球T细胞疗法市场：按适应症（血液恶性肿瘤,实体瘤,其他）,治疗类型（CAR T细胞疗法,基于TCR,基于TIL）,方式（研究,商业化）,地区2023-2033
市场调查报告书
商品编码
1229629

全球T细胞疗法市场：按适应症（血液恶性肿瘤,实体瘤,其他）,治疗类型（CAR T细胞疗法,基于TCR,基于TIL）,方式（研究,商业化）,地区2023-2033

Global T-cell Therapy Market by Indication (Hematologic Malignancies, Solid Tumours and Other Indications), by Therapy Type (CAR T-cell Therapy, TCR-based and TIL-based), by Modality (Research and Commercialized) and Region - 2023 to 2033
出版日期: | 出版商: Transparency Market Research | 英文 250 Pages | 商品交期: 2-10个工作天内

价格

TMR 的研究报告“全球 T 细胞治疗市场”不仅包括过去的增长趋势，还包括当前的增长趋势和机会，以深入了解 2023 年至 2033 年预测期间的市场指标。我们正在调查。 本报告介绍了 2017 年至 2031 年全球 T 细胞治疗市场的收入，基准年为 2023 年，预测年为 2033 年。 它还展示了 2023 年至 2033 年全球 T 细胞治疗市场的复合年增长率 (CAGR %)。

这份报告是广泛研究的结果。 在初步研究中，分析师对主要思想领袖,行业领袖和舆论製造者进行访谈，他们提供了大量的研究工作。 在我们的二次研究中，我们通过参考主要公司的产品文献,年度报告,新闻稿和相关文件确定了 T 细胞疗法市场。

该报告深入探讨了全球 T 细胞疗法市场的竞争格局。 已经确定了在全球 T 细胞治疗市场运营的主要参与者，并且对每家公司进行了不同属性的分析。 公司概况,财务状况,近期市场发展和 SWOT 是本报告中描述的全球 T 细胞治疗市场参与者的属性。

内容

第 1 章执行摘要

  • 世界市场展望
  • 需求方面的趋势
  • 供应方趋势
  • 技术路线图分析
  • 分析和建议

第 2 章市场概述

  • 市场覆盖/分类
  • 市场定义/范围/限制

第三章市场背景

  • 市场动态
    • 司机
    • 约束因素
    • 机会
    • 趋势
  • 情景预测
    • 乐观情景下的需求趋势
    • 假设情景中的需求
    • 保守情景下的需求
  • 机会地图分析
  • 投资可行性矩阵
  • 价值链分析
    • 利润率分析
    • 服务提供商
  • PESTLE 分析和 Porters 分析
  • 监管状况
    • 按主要地区
    • 按国家
  • 区域亲子市场展望

第 4 章 2018-2022 年全球 T 细胞疗法市场分析和 2023-2033 年预测

  • 2018-2022 年实际市场规模分析
  • 2023-2033 年当前和未来市场规模价值预测
    • 同比增长趋势分析
    • 绝对数量机会分析

第 5 章 2018-2022 年全球 T 细胞疗法市场分析和 2023-2033 年预测：按适应症分类

  • 简介/主要评论
  • 2018-2022 年各适应症的市场规模价值分析
  • 2023-2033 年当前和未来市场规模价值分析和预测（按适应症分类）
    • 血液系统恶性肿瘤
      • 淋巴瘤
      • 白血病
      • 骨髓瘤
    • 实体癌
      • 黑色素瘤
      • 大脑和中枢神经系统
      • 肝癌
      • 其他实体瘤
    • 其他适应症
  • Yo-Y 增长趋势分析（按适应症），2018-2022 年
  • 按适应症分类的绝对机会分析，2023 年至 2033 年

第 6 章 2018-2022 年全球 T 细胞疗法市场分析，2023-2033 年预测：按治疗类型

  • 简介/主要评论
  • 2018-2022 年各治疗类型的市场规模价值分析
  • 2023-2033 年按治疗类型划分的当前和未来市场规模价值分析和预测
    • CAR T 细胞疗法
    • 基于 T 细胞受体 (TCR)
    • 基于肿瘤浸润淋巴细胞 (TIL)
  • 2018-2022 年按治疗类型分类的同比增长趋势分析
  • 按治疗类型分类的绝对数量机会分析 (2023-2033)

第 7 章 2018-2022 年全球 T 细胞疗法市场分析和 2023-2033 年预测：按模式

  • 简介/主要评论
  • 2018-2022 年各模式的市场规模绩效价值分析
  • 2023-2033 年当前和未来市场规模价值分析和预测（按模式）
    • 调查
    • 商业化
  • 2018-2022 年各模式的同比增长趋势分析
  • 2023-2033 年按形态分类的绝对数量机会分析

第 8 章 2018-2022 年全球 T 细胞疗法市场分析，2023-2033 年预测：按地区

  • 介绍
  • 2018-2022 年各地区市场规模分析
  • 2023-2033 年当前市场规模价值分析和区域预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东和非洲
  • 各地区的市场吸引力分析

第 9 章 2018-2022 年北美 T 细胞疗法市场分析和 2023-2033 年预测：按国家/地区分类

  • 2018-2022 年按市场分类的市场规模表现趋势分析
  • 按市场分类预测的市场规模，2023 年至 2033 年
    • 按国家
      • 美国
      • 加拿大
    • 按视图
    • 按治疗类型
    • 按方式
  • 市场吸引力分析
    • 按国家
    • 按视图
    • 按治疗类型
    • 按方式
  • 钥匙带走

第 10 章拉丁美洲 T 细胞疗法市场分析 2018-2022 和预测 2023-2033：按国家/地区

  • 2018-2022 年按市场分类的市场规模表现趋势分析
  • 按市场分类预测的市场规模，2023 年至 2033 年
    • 按国家
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区
    • 按视图
    • 按治疗类型
    • 按方式
  • 市场吸引力分析
    • 按国家
    • 按视图
    • 按治疗类型
    • 按方式
  • 钥匙带走

第 11 章欧洲 T 细胞疗法市场分析 2018-2022 和预测 2023-2033：按国家/地区

  • 2018-2022 年按市场分类的市场规模表现趋势分析
  • 按市场分类预测的市场规模，2023 年至 2033 年
    • 按国家
      • 德国
      • 意大利
      • 法国
      • 英国
      • 西班牙
      • 俄罗斯
      • 其他欧洲
    • 按视图
    • 按治疗类型
    • 按方式
  • 市场吸引力分析
    • 按国家
    • 按视图
    • 按治疗类型
    • 按方式
  • 钥匙带走

第 12 章亚太地区 T 细胞疗法市场分析 2018-2022 和预测 2023-2033：按国家/地区

  • 2018-2022 年按市场分类的市场规模表现趋势分析
  • 按市场分类预测的市场规模，2023 年至 2033 年
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 澳大利亚
      • 亚太地区的其他国家
    • 按视图
    • 按治疗类型
    • 按方式
  • 市场吸引力分析
    • 按国家
    • 按视图
    • 按治疗类型
    • 按方式
  • 钥匙带走

第 13 章中东和非洲 T 细胞疗法市场分析 2018-2022 和预测 2023-2033：按国家/地区

  • 2018-2022 年按市场分类的市场规模表现趋势分析
  • 按市场分类预测的市场规模，2023 年至 2033 年
    • 按国家
      • 南非
      • 沙特阿拉伯
      • 阿联酋
      • 以色列
      • 其余中东和非洲地区
    • 按视图
    • 按治疗类型
    • 按方式
  • 市场吸引力分析
    • 按国家
    • 按视图
    • 按治疗类型
    • 按方式
  • 钥匙带走

第14章主要国家T细胞治疗市场分析

  • 美国
    • 价格分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 加拿大
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 巴西
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 墨西哥
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 德国
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 意大利
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 法国
    • 价格分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 英国
    • 价格分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 西班牙
    • 价格分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 俄罗斯
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 中国
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 日本
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 印度
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 韩国
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 澳大利亚
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 南非
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 沙特阿拉伯
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 阿联酋
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式
  • 以色列
    • 定价分析
    • 2022 年市场份额分析
      • 按视图
      • 按治疗类型
      • 按方式

第15章市场结构分析

  • 比赛仪表板
  • 竞争基准
  • 顶级公司的市场份额分析
    • 按地区
    • 按视图
    • 按治疗类型
    • 按方式

第 16 章竞争分析

  • 探索竞争的深度
    • Novartis AG
    • Merck KGaA
    • Gilead Sciences Inc.
    • TCR2 Therapeutics Inc
    • Bluebird Bio Inc
    • Sorrento Therapeutics
    • Fate Therapeutics
    • Pfizer Inc
    • Amgen
    • Celgene Corporation

第 17 章使用假设和缩写

第 18 章研究方法论

Product Code: TMRGL75857

The report provides revenue of the global T-cell therapy market for the period 2017-2031, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global T-cell therapy market from 2023 to 2033.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the T-cell therapy market.

The report delves into the competitive landscape of the global T-cell therapy market. Key players operating in the global T-cell therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global T-cell therapy market profiled in this report.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. Value Chain Analysis
    • 3.5.1. Profit Margin Analysis
    • 3.5.2. Service Providers
  • 3.6. PESTLE and Porter's Analysis
  • 3.7. Regulatory Landscape
    • 3.7.1. By Key Regions
    • 3.7.2. By Key Countries
  • 3.8. Regional Parent Market Outlook

4. Global T-cell Therapy Market Analysis 2018-2022 and Forecast, 2023-2033

  • 4.1. Historical Market Size Value (US$ Bn) Analysis, 2018-2022
  • 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2023-2033
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Indication

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Bn) Analysis By Indication , 2018-2022
  • 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Indication , 2023-2033
    • 5.3.1. Hematologic Malignancies
      • 5.3.1.1. Lymphoma
      • 5.3.1.2. Leukemia
      • 5.3.1.3. Myeloma
    • 5.3.2. Solid Tumors
      • 5.3.2.1. Melanoma
      • 5.3.2.2. Brain & Central Nervous System
      • 5.3.2.3. Liver Cancer
      • 5.3.2.4. Other Solid Tumors
    • 5.3.3. Other Indications
  • 5.4. Y-o-Y Growth Trend Analysis By Indication , 2018-2022
  • 5.5. Absolute $ Opportunity Analysis By Indication , 2023-2033

6. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Therapy Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Bn) Analysis By Therapy Type, 2018-2022
  • 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Therapy Type, 2023-2033
    • 6.3.1. CAR T-cell Therapy
    • 6.3.2. T Cell Receptor (TCR)-based
    • 6.3.3. Tumor Infiltrating Lymphocytes (TIL)-based
  • 6.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2018-2022
  • 6.5. Absolute $ Opportunity Analysis By Therapy Type, 2023-2033

7. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Modality

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Bn) Analysis By Modality , 2018-2022
  • 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Modality , 2023-2033
    • 7.3.1. Research
    • 7.3.2. Commercialized
  • 7.4. Y-o-Y Growth Trend Analysis By Modality , 2018-2022
  • 7.5. Absolute $ Opportunity Analysis By Modality , 2023-2033

8. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2018-2022
  • 8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2023-2033
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. Asia Pacific
    • 8.3.5. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 9.2.1. By Country
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
    • 9.2.2. By Indication
    • 9.2.3. By Therapy Type
    • 9.2.4. By Modality
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Indication
    • 9.3.3. By Therapy Type
    • 9.3.4. By Modality
  • 9.4. Key Takeaways

10. Latin America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Rest of Latin America
    • 10.2.2. By Indication
    • 10.2.3. By Therapy Type
    • 10.2.4. By Modality
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Indication
    • 10.3.3. By Therapy Type
    • 10.3.4. By Modality
  • 10.4. Key Takeaways

11. Europe T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. Italy
      • 11.2.1.3. France
      • 11.2.1.4. U.K.
      • 11.2.1.5. Spain
      • 11.2.1.6. Russia
      • 11.2.1.7. Rest of Europe
    • 11.2.2. By Indication
    • 11.2.3. By Therapy Type
    • 11.2.4. By Modality
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Indication
    • 11.3.3. By Therapy Type
    • 11.3.4. By Modality
  • 11.4. Key Takeaways

12. Asia Pacific T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. India
      • 12.2.1.4. South Korea
      • 12.2.1.5. Australia
      • 12.2.1.6. Rest of APAC
    • 12.2.2. By Indication
    • 12.2.3. By Therapy Type
    • 12.2.4. By Modality
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Indication
    • 12.3.3. By Therapy Type
    • 12.3.4. By Modality
  • 12.4. Key Takeaways

13. MEA T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

  • 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
    • 13.2.1. By Country
      • 13.2.1.1. South Africa
      • 13.2.1.2. Saudi Arabia
      • 13.2.1.3. UAE
      • 13.2.1.4. Israel
      • 13.2.1.5. Rest of MEA
    • 13.2.2. By Indication
    • 13.2.3. By Therapy Type
    • 13.2.4. By Modality
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Indication
    • 13.3.3. By Therapy Type
    • 13.3.4. By Modality
  • 13.4. Key Takeaways

14. Key Countries T-cell Therapy Market Analysis

  • 14.1. U.S.
    • 14.1.1. Pricing Analysis
    • 14.1.2. Market Share Analysis, 2022
      • 14.1.2.1. By Indication
      • 14.1.2.2. By Therapy Type
      • 14.1.2.3. By Modality
  • 14.2. Canada
    • 14.2.1. Pricing Analysis
    • 14.2.2. Market Share Analysis, 2022
      • 14.2.2.1. By Indication
      • 14.2.2.2. By Therapy Type
      • 14.2.2.3. By Modality
  • 14.3. Brazil
    • 14.3.1. Pricing Analysis
    • 14.3.2. Market Share Analysis, 2022
      • 14.3.2.1. By Indication
      • 14.3.2.2. By Therapy Type
      • 14.3.2.3. By Modality
  • 14.4. Mexico
    • 14.4.1. Pricing Analysis
    • 14.4.2. Market Share Analysis, 2022
      • 14.4.2.1. By Indication
      • 14.4.2.2. By Therapy Type
      • 14.4.2.3. By Modality
  • 14.5. Germany
    • 14.5.1. Pricing Analysis
    • 14.5.2. Market Share Analysis, 2022
      • 14.5.2.1. By Indication
      • 14.5.2.2. By Therapy Type
      • 14.5.2.3. By Modality
  • 14.6. Italy
    • 14.6.1. Pricing Analysis
    • 14.6.2. Market Share Analysis, 2022
      • 14.6.2.1. By Indication
      • 14.6.2.2. By Therapy Type
      • 14.6.2.3. By Modality
  • 14.7. France
    • 14.7.1. Pricing Analysis
    • 14.7.2. Market Share Analysis, 2022
      • 14.7.2.1. By Indication
      • 14.7.2.2. By Therapy Type
      • 14.7.2.3. By Modality
  • 14.8. U.K.
    • 14.8.1. Pricing Analysis
    • 14.8.2. Market Share Analysis, 2022
      • 14.8.2.1. By Indication
      • 14.8.2.2. By Therapy Type
      • 14.8.2.3. By Modality
  • 14.9. Spain
    • 14.9.1. Pricing Analysis
    • 14.9.2. Market Share Analysis, 2022
      • 14.9.2.1. By Indication
      • 14.9.2.2. By Therapy Type
      • 14.9.2.3. By Modality
  • 14.10. Russia
    • 14.10.1. Pricing Analysis
    • 14.10.2. Market Share Analysis, 2022
      • 14.10.2.1. By Indication
      • 14.10.2.2. By Therapy Type
      • 14.10.2.3. By Modality
  • 14.11. China
    • 14.11.1. Pricing Analysis
    • 14.11.2. Market Share Analysis, 2022
      • 14.11.2.1. By Indication
      • 14.11.2.2. By Therapy Type
      • 14.11.2.3. By Modality
  • 14.12. Japan
    • 14.12.1. Pricing Analysis
    • 14.12.2. Market Share Analysis, 2022
      • 14.12.2.1. By Indication
      • 14.12.2.2. By Therapy Type
      • 14.12.2.3. By Modality
  • 14.13. India
    • 14.13.1. Pricing Analysis
    • 14.13.2. Market Share Analysis, 2022
      • 14.13.2.1. By Indication
      • 14.13.2.2. By Therapy Type
      • 14.13.2.3. By Modality
  • 14.14. South Korea
    • 14.14.1. Pricing Analysis
    • 14.14.2. Market Share Analysis, 2022
      • 14.14.2.1. By Indication
      • 14.14.2.2. By Therapy Type
      • 14.14.2.3. By Modality
  • 14.15. Australia
    • 14.15.1. Pricing Analysis
    • 14.15.2. Market Share Analysis, 2022
      • 14.15.2.1. By Indication
      • 14.15.2.2. By Therapy Type
      • 14.15.2.3. By Modality
  • 14.16. South Africa
    • 14.16.1. Pricing Analysis
    • 14.16.2. Market Share Analysis, 2022
      • 14.16.2.1. By Indication
      • 14.16.2.2. By Therapy Type
      • 14.16.2.3. By Modality
  • 14.17. Saudi Arabia
    • 14.17.1. Pricing Analysis
    • 14.17.2. Market Share Analysis, 2022
      • 14.17.2.1. By Indication
      • 14.17.2.2. By Therapy Type
      • 14.17.2.3. By Modality
  • 14.18. UAE
    • 14.18.1. Pricing Analysis
    • 14.18.2. Market Share Analysis, 2022
      • 14.18.2.1. By Indication
      • 14.18.2.2. By Therapy Type
      • 14.18.2.3. By Modality
  • 14.19. Israel
    • 14.19.1. Pricing Analysis
    • 14.19.2. Market Share Analysis, 2022
      • 14.19.2.1. By Indication
      • 14.19.2.2. By Therapy Type
      • 14.19.2.3. By Modality

15. Market Structure Analysis

  • 15.1. Competition Dashboard
  • 15.2. Competition Benchmarking
  • 15.3. Market Share Analysis of Top Players
    • 15.3.1. By Regional
    • 15.3.2. By Indication
    • 15.3.3. By Therapy Type
    • 15.3.4. By Modality

16. Competition Analysis

  • 16.1. Competition Deep Dive
    • 16.1.1. Novartis AG
      • 16.1.1.1. Overview
      • 16.1.1.2. Product Portfolio
      • 16.1.1.3. Profitability by Market Segments
      • 16.1.1.4. Sales Footprint
      • 16.1.1.5. Strategy Overview
        • 16.1.1.5.1. Marketing Strategy
        • 16.1.1.5.2. Product Strategy
        • 16.1.1.5.3. Channel Strategy
    • 16.1.2. Merck KGaA
      • 16.1.2.1. Overview
      • 16.1.2.2. Product Portfolio
      • 16.1.2.3. Profitability by Market Segments
      • 16.1.2.4. Sales Footprint
      • 16.1.2.5. Strategy Overview
        • 16.1.2.5.1. Marketing Strategy
        • 16.1.2.5.2. Product Strategy
        • 16.1.2.5.3. Channel Strategy
    • 16.1.3. Gilead Sciences Inc.
      • 16.1.3.1. Overview
      • 16.1.3.2. Product Portfolio
      • 16.1.3.3. Profitability by Market Segments
      • 16.1.3.4. Sales Footprint
      • 16.1.3.5. Strategy Overview
        • 16.1.3.5.1. Marketing Strategy
        • 16.1.3.5.2. Product Strategy
        • 16.1.3.5.3. Channel Strategy
    • 16.1.4. TCR2 Therapeutics Inc
      • 16.1.4.1. Overview
      • 16.1.4.2. Product Portfolio
      • 16.1.4.3. Profitability by Market Segments
      • 16.1.4.4. Sales Footprint
      • 16.1.4.5. Strategy Overview
        • 16.1.4.5.1. Marketing Strategy
        • 16.1.4.5.2. Product Strategy
        • 16.1.4.5.3. Channel Strategy
    • 16.1.5. Bluebird Bio Inc
      • 16.1.5.1. Overview
      • 16.1.5.2. Product Portfolio
      • 16.1.5.3. Profitability by Market Segments
      • 16.1.5.4. Sales Footprint
      • 16.1.5.5. Strategy Overview
        • 16.1.5.5.1. Marketing Strategy
        • 16.1.5.5.2. Product Strategy
        • 16.1.5.5.3. Channel Strategy
    • 16.1.6. Sorrento Therapeutics
      • 16.1.6.1. Overview
      • 16.1.6.2. Product Portfolio
      • 16.1.6.3. Profitability by Market Segments
      • 16.1.6.4. Sales Footprint
      • 16.1.6.5. Strategy Overview
        • 16.1.6.5.1. Marketing Strategy
        • 16.1.6.5.2. Product Strategy
        • 16.1.6.5.3. Channel Strategy
    • 16.1.7. Fate Therapeutics
      • 16.1.7.1. Overview
      • 16.1.7.2. Product Portfolio
      • 16.1.7.3. Profitability by Market Segments
      • 16.1.7.4. Sales Footprint
      • 16.1.7.5. Strategy Overview
        • 16.1.7.5.1. Marketing Strategy
        • 16.1.7.5.2. Product Strategy
        • 16.1.7.5.3. Channel Strategy
    • 16.1.8. Pfizer Inc
      • 16.1.8.1. Overview
      • 16.1.8.2. Product Portfolio
      • 16.1.8.3. Profitability by Market Segments
      • 16.1.8.4. Sales Footprint
      • 16.1.8.5. Strategy Overview
        • 16.1.8.5.1. Marketing Strategy
        • 16.1.8.5.2. Product Strategy
        • 16.1.8.5.3. Channel Strategy
    • 16.1.9. Amgen
      • 16.1.9.1. Overview
      • 16.1.9.2. Product Portfolio
      • 16.1.9.3. Profitability by Market Segments
      • 16.1.9.4. Sales Footprint
      • 16.1.9.5. Strategy Overview
        • 16.1.9.5.1. Marketing Strategy
        • 16.1.9.5.2. Product Strategy
        • 16.1.9.5.3. Channel Strategy
    • 16.1.10. Celgene Corporation
      • 16.1.10.1. Overview
      • 16.1.10.2. Product Portfolio
      • 16.1.10.3. Profitability by Market Segments
      • 16.1.10.4. Sales Footprint
      • 16.1.10.5. Strategy Overview
        • 16.1.10.5.1. Marketing Strategy
        • 16.1.10.5.2. Product Strategy
        • 16.1.10.5.3. Channel Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

List of Tables

  • Table 1: Global T-cell Therapy Market Value (US$ Bn) Forecast by Region, 2018-2033
  • Table 2: Global T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 3: Global T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 4: Global T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 5: North America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 6: North America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 7: North America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 8: North America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 9: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 10: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 11: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 12: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 13: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 14: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 15: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 16: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 17: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 18: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 19: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 20: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
  • Table 21: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
  • Table 22: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
  • Table 23: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
  • Table 24: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033

List of Figures

  • Figure 1: Global T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 2: Global T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 3: Global T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 4: Global T-cell Therapy Market Value (US$ Bn) by Region, 2023-2033
  • Figure 5: Global T-cell Therapy Market Value (US$ Bn) Analysis by Region, 2018-2033
  • Figure 6: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Region, 2023-2033
  • Figure 7: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Region, 2023-2033
  • Figure 8: Global T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 9: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 10: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 11: Global T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 12: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 13: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 14: Global T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 15: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 16: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 17: Global T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 18: Global T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 19: Global T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 20: Global T-cell Therapy Market Attractiveness by Region, 2023-2033
  • Figure 21: North America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 22: North America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 23: North America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 24: North America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 25: North America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 26: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 27: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 28: North America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 29: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 30: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 31: North America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 32: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 33: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 34: North America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 35: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 36: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 37: North America T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 38: North America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 39: North America T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 40: North America T-cell Therapy Market Attractiveness by Country, 2023-2033
  • Figure 41: Latin America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 42: Latin America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 43: Latin America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 44: Latin America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 45: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 46: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 47: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 48: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 49: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 50: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 51: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 52: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 53: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 54: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 55: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 56: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 57: Latin America T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 58: Latin America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 59: Latin America T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 60: Latin America T-cell Therapy Market Attractiveness by Country, 2023-2033
  • Figure 61: Europe T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 62: Europe T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 63: Europe T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 64: Europe T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 65: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 66: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 67: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 68: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 69: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 70: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 71: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 72: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 73: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 74: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 75: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 76: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 77: Europe T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 78: Europe T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 79: Europe T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 80: Europe T-cell Therapy Market Attractiveness by Country, 2023-2033
  • Figure 81: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 82: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 83: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 84: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 85: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 86: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 87: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 88: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 89: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 90: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 91: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 92: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 93: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 94: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 95: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 96: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 97: Asia Pacific T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 98: Asia Pacific T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 99: Asia Pacific T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 100: Asia Pacific T-cell Therapy Market Attractiveness by Country, 2023-2033
  • Figure 101: MEA T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
  • Figure 102: MEA T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
  • Figure 103: MEA T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
  • Figure 104: MEA T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
  • Figure 105: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
  • Figure 106: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
  • Figure 107: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
  • Figure 108: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
  • Figure 109: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
  • Figure 110: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
  • Figure 111: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
  • Figure 112: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
  • Figure 113: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
  • Figure 114: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
  • Figure 115: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
  • Figure 116: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
  • Figure 117: MEA T-cell Therapy Market Attractiveness by Indication , 2023-2033
  • Figure 118: MEA T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
  • Figure 119: MEA T-cell Therapy Market Attractiveness by Modality , 2023-2033
  • Figure 120: MEA T-cell Therapy Market Attractiveness by Country, 2023-2033